Novartis malaria treatment Coartem® Baby receives WHO prequalification

 

• Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment gap
  
  
• WHO prequalification key milestone for donor-funded and public sector purchasing by UN and other procurement agencies

https://www.novartis.com/us-en/news/media-releases/novartis-malaria-treatment-coartem-baby-receives-who-prequalification-paving-way-greater-access-newborns-and-young-infants